Leman Biotech

Lausanne, Switzerland

Leman Biotech is a biotech company that is engaged in development of cancer immunotherapies.

$28.8M raised

Jan 2026

Series A

Biotechnology Health Care Medical Pharmaceutical

Top Investors

Mony Valley Mining World Star XtalPi Tiantu Capital Fuho Capital

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Leman Biotech

How much funding has Leman Biotech raised?

Leman Biotech has raised $28.8M in total funding. The most recent round was Series A. The last funding was announced in January 2026.

Who are Leman Biotech's investors?

Leman Biotech's investors include Mony Valley, Mining World Star, XtalPi, Tiantu Capital, Fuho Capital.

Where is Leman Biotech headquartered?

Leman Biotech is headquartered in Lausanne, Switzerland.

What does Leman Biotech do?

Leman Biotech is a biotech company that is engaged in development of cancer immunotherapies.

What stage is Leman Biotech at?

Leman Biotech is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 26, 2026.

MLA

"Leman Biotech — Funding & Investors." VCBacked, January 26, 2026, https://www.vcbacked.co/company/leman-biotech. Accessed July 2, 2026.

APA

VCBacked. (2026). Leman Biotech — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/leman-biotech

Wikipedia (cite web)

{{cite web |title=Leman Biotech — Funding & Investors |url=https://www.vcbacked.co/company/leman-biotech |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 26, 2026.

Similar Companies in Biotechnology

View all

Rapport Therapeutics

Boston$250.0M

Renaissance BioScience

Vancouver$599K

Allterum Therapeutics

Advanced Microbiome Interventions

Amsterdam$300K